Thanks cgt2009 and fair enough. My thinking was why would BOTA...

Thanks cgt2009 and fair enough. My thinking was why would BOTA want to slim down by cutting out their pre clinical development, which is their long term future, other than trying to make themselves look more palatable to an acquirer?

I guess a potential partner may say why would we look to partner with BOTA on one of it's programmes when we can buy the whole company with a nice cash balance for a whole lot less than any partnership deal may cost?